Research
Print page
Switch language
Rigshospitalet
- a part of Copenhagen University Hospital
Published
Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production
Research output: Contribution to journal › Journal article › Research › peer-review
Treatment with interferon-beta (IFN-beta) increases B-cell activating factor of the TNF family (BAFF) expression in multiple sclerosis (MS), raising the concern that treatment of MS patients with IFN-beta may activate autoimmune B cells and stimulate the production of MS-associated autoantibodies.
| Original language | English |
|---|---|
| Journal | Multiple Sclerosis |
| Volume | 17 |
| Issue number | 5 |
| Pages (from-to) | 567-77 |
| Number of pages | 11 |
| ISSN | 1352-4585 |
| DOIs | |
| Publication status | Published - 1 May 2011 |
ID: 32672948